Petmed Express logo Petmed Express (NASDAQ:PETS) was upgraded by equities research analysts at BidaskClub from a “sell” rating to a “hold” rating in a note issued to investors on Wednesday, January 16th.
PETS has been the subject of several other research reports. ValuEngine upgraded shares of Petmed Express from a “strong sell” rating to a “sell” rating in a report on Friday, October 26th. TheStreet lowered shares of Petmed Express from a “b” rating to a “c+” rating in a report on Thursday, November 29th. Two equities research analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $28.00.
PETS traded up $1.06 on Wednesday, reaching $21.99. 1,699,280 shares of the company traded hands, compared to its average volume of 1,005,499. Petmed Express has a one year low of $20.25 and a one year high of $50.98. The firm has a market capitalization of $484.60 million, a price-to-earnings ratio of 11.27 and a beta of 0.74.
Petmed Express (NASDAQ:PETS) last announced its quarterly earnings data on Tuesday, January 22nd. The company reported $0.38 earnings per share for the quarter, missing analysts’ consensus estimates of $0.48 by ($0.10). Petmed Express had a net margin of 14.88% and a return on equity of 35.53%. The company had revenue of $60.10 million for the quarter, compared to the consensus estimate of $64.22 million. During the same quarter in the previous year, the business earned $0.44 EPS. The company’s quarterly revenue was up .0% compared to the same quarter last year.
Several hedge funds and other institutional investors have recently bought and sold shares of PETS. Public Employees Retirement Association of Colorado raised its stake in shares of Petmed Express by 265.5% during the 3rd quarter. Public Employees Retirement Association of Colorado now owns 3,922 shares of the company’s stock worth $129,000 after acquiring an additional 2,849 shares in the last quarter. First Hawaiian Bank bought a new position in shares of Petmed Express during the 4th quarter worth approximately $193,000. OppenheimerFunds Inc. purchased a new stake in Petmed Express during the 2nd quarter worth approximately $205,000. Schroder Investment Management Group purchased a new stake in Petmed Express during the 2nd quarter worth approximately $214,000. Finally, Point72 Asset Management L.P. purchased a new stake in Petmed Express during the 2nd quarter worth approximately $229,000. Hedge funds and other institutional investors own 95.20% of the company’s stock.
Petmed Express Company Profile
PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Recommended Story: Risk Tolerance and Your Investment Decisions
Receive News & Ratings for Petmed Express Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Petmed Express and related companies with MarketBeat.com’s FREE daily email newsletter .
Click here to view original web page at Petmed Express (NASDAQ:PETS) Upgraded to “Hold” at BidaskClub